US CDC advisers begin review of vaccine guidelines after months-long delay
- QUANTUNG PHARMA
- Apr 14
- 1 min read
Summary
Companies
Panel to discuss guidelines for RSV and chikungunya vaccines
COVID vaccine recommendations for 2025-2026 season under review
CDC's chief of staff to decide on panel's recommendations, HHS says
April 15 (Reuters) - The U.S. Centers for Disease Control and Prevention's outside expert panel began a two-day meeting on Tuesday after a nearly two-month delay during which it will review guidelines for several vaccines and discuss narrowing recommendations on COVID-19 booster shots.
The panel will vote on Wednesday about recommendations for three vaccines, including for respiratory syncytial virus and chikungunya, a mosquito-borne disease.
